N F Orel Selected Research

Ovarian Neoplasms (Ovarian Cancer)

1/2013	[Which patients with ovarian cancer shows the combination of trabectedin with pegylated liposomal doxorubicin].
1/2002	[Comparative pharmaco-economic analysis of docetaxel with cisplatin and cyclophosphamide with cisplatin in first-line chemotherapy of advanced ovarian cancer].
1/2001	[Efficacy and toxicity of a taxotere/cisplatin combination in first line chemotherapy in patients with disseminated ovarian cancer].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

N F Orel Research Topics

Disease

3	Ovarian Neoplasms (Ovarian Cancer) 01/2013 - 01/2001
2	Neoplasms (Cancer) 01/2003 - 01/2001
1	Merkel Cell Carcinoma 06/2018
1	Stomach Neoplasms (Stomach Cancer) 01/2006
1	Leukopenia 01/2001
1	Thrombocytopenia (Thrombopenia) 01/2001
1	Melanoma (Melanoma, Malignant) 05/2000

Drug/Important Bio-Agent (IBA)

3	Cisplatin (Platino)FDA LinkGeneric 01/2006 - 01/2001
2	Docetaxel (Taxotere)FDA Link 01/2002 - 01/2001
1	somatostatin receptor 2IBA 06/2018
1	liposomal doxorubicin (Doxil)FDA Link 01/2013
1	PlatinumIBA 01/2013
1	TrabectedinIBA 01/2013
1	Fluorouracil (Carac)FDA LinkGeneric 01/2006
1	Capecitabine (Xeloda)FDA Link 01/2003
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2002
1	Therapeutic UsesIBA 01/2001
1	nitrullinIBA 01/2001
1	Interferon-alpha (Interferon Alfa)IBA 05/2000

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2002 - 05/2000
1	Therapeutics 01/2013